The Trump administration delivered a decisive blow to radical gender ideology by announcing sweeping proposals to cut federal funding from hospitals providing experimental transgender procedures to children.
Story Highlights
- HHS proposes cutting Medicaid and Medicare funding from hospitals providing gender-affirming care to minors
- Health Secretary RFK Jr. condemns procedures as “malpractice” that “rob children of their futures”
- FDA issues warning letters to companies marketing chest-binding equipment to minors
- Proposals would impact nearly two dozen states where such treatments remain legal and Medicaid-funded
Administration Takes Stand Against Medical Experimentation on Children
The Department of Health and Human Services unveiled regulatory proposals Thursday to eliminate federal funding for hospitals performing gender-affirming procedures on minors. Health Secretary Robert F. Kennedy Jr. condemned these treatments as “malpractice,” declaring that “sex-rejecting procedures rob children of their futures.”
The announcement represents the administration’s most significant action yet to protect children from irreversible medical interventions that many conservatives view as ideologically driven rather than medically necessary.
Trump administration unveils proposals to cut off transgender care for minors https://t.co/dYcUQa635D
— CBS Mornings (@CBSMornings) December 18, 2025
Financial Leverage Targets Progressive Medical Establishment
The proposed rules would strip Medicaid and Medicare payments from healthcare providers offering puberty blockers, hormone therapy, and surgical interventions to transgender children.
Nearly all U.S. hospitals rely on these federal programs, which serve seniors, people with disabilities, and low-income Americans.
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, characterized transgender treatments as “a Band-Aid on a much deeper pathology,” suggesting children with gender dysphoria are “confused, lost, and need help.”
Broad Support Backs Traditional Values Approach
The administration’s position reflects widespread public sentiment, with Associated Press polling showing approximately half of Americans approve of Trump’s handling of transgender issues.
Conservative activist Chloe Cole, who reversed her own gender transition, praised the administration’s actions, stating that cries for help from detransitioners “have finally been heard.”
The proposals align with existing restrictions in 27 states that have already banned or limited such procedures, demonstrating growing recognition that protecting children from experimental treatments serves the public interest.
These regulatory proposals require public comment periods and formal rulemaking processes before becoming permanent.
However, many hospitals have already ceased providing gender-affirming care to minors in anticipation of federal restrictions. The administration also announced plans to exclude gender dysphoria from the federal disability definition.
It issued FDA warning letters to companies marketing chest-binding equipment to minors, including GenderBender LLC and TomboyX, requiring that such products meet legitimate medical-use standards.
Constitutional Protections for Parental Rights and Child Welfare
The initiative builds upon President Trump’s first-day executive orders recognizing only the biological male and female sexes and restricting federal support for gender transitions under age 19.
Congressional Republicans are advancing complementary legislation, including bills imposing prison sentences for providers treating minors and banning Medicaid coverage for such procedures.
This comprehensive approach prioritizes parental rights and child protection over progressive ideology, ensuring federal resources support proven medical treatments rather than experimental procedures that may cause lifelong harm to vulnerable children.
